Sinopharm
1099.HK
#2337
Rank
โ‚น752.79 B
Marketcap
โ‚น241.23
Share price
-3.25%
Change (1 day)
25.50%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.476 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.476 Trillion. In 2024 the company made a revenue of โ‚น7.476 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.878 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.476 T-5.1%
2023โ‚น7.878 T5.42%
2022โ‚น7.472 T-2.1%
2021โ‚น7.632 T16.85%
2020โ‚น6.532 T14.95%
2019โ‚น5.682 T21.52%
2018โ‚น4.676 T5.93%
2017โ‚น4.414 T27.22%
2016โ‚น3.469 T5.37%
2015โ‚น3.292 T9.14%
2014โ‚น3.016 T17.22%
2013โ‚น2.573 T25.94%
2012โ‚น2.043 T34.61%
2011โ‚น1.518 T55.34%
2010โ‚น977.34 B35.79%
2009โ‚น719.75 B37.56%
2008โ‚น523.24 B31.43%
2007โ‚น398.12 B40.26%
2006โ‚น283.84 B